跳至主要内容
临床试验/NL-OMON45755
NL-OMON45755已完成不适用

Optical Coherence Tomography to visualize neuropathology in Alzheimer's disease - OCT in AD

Vrije Universiteit Medisch Centrum0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Study cases: patients with AD fulfilling the clinical criteria, a MMSE-score of at least 17/30 and proven to be amyloid positive by either decreased CSF A* or a positive amyloid PET scan.
  • - Controls: patients with subjective memory complaints visiting the Alzheimer center, without diagnosis of AD or other neurodegenerative disease, proven to be amyloid negative by either normal CSF A* or negative amyloid PET scan.

排除标准

  • - Subjects with neuro-opthalmological conditions which may interfere with the OCT data
  • - Subjects with progressive dementia, with an MMSE below 17/30 and/or incapacitated and not capable to give informed consent.

研究者

相似试验

Optical Coherence Tomography to visualize... | 临床试验